Updates in Medicine articles by specialty
Rheumatology
1 article · Newest first
FDA Approves Brepocitinib: The First Oral Treatment for Adult Dermatomyositis
Lisraya becomes the first FDA-approved oral therapy specifically indicated for adults with dermatomyositis.